MIGUEL DIAZ: Open Payments
NPI 1629511290 · DORAL, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,069 in 38 payments from 8 companies in 2025. Trend: 2023 $633 · 2024 $569 · 2025 $1,069
Food & beverage: $1,069
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 21 | $570 |
| Otsuka America Pharmaceutical, Inc. | 7 | $159 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $157 |
| E.R. Squibb & Sons, L.L.C. | 3 | $81 |
| Janssen Biotech, Inc. | 1 | $34 |
| Neurocrine BioSciences, Inc. | 1 | $28 |
| Almatica Pharma LLC | 1 | $21 |
| Janssen Pharmaceuticals, Inc | 1 | $19 |
Products named: VRAYLAR, REXULTI, CAPLYTA, COBENFY, TECVAYLI, INGREZZA, LOREEV XR, SPRAVATO.
Industry payments across FL — which companies pay providers there.
